Affordable Access

Access to the full text

Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?

Authors
  • Groheux, David1, 2
  • Hindié, Elif3
  • 1 Saint-Louis Hospital, Department of Nuclear Medicine, Paris, France , Paris (France)
  • 2 University Paris-Diderot, INSERM/CNRS UMR944/7212, Paris, France , Paris (France)
  • 3 Bordeaux University Hospital, Department of Nuclear Medicine, Bordeaux, France , Bordeaux (France)
Type
Published Article
Journal
European Journal of Nuclear Medicine
Publisher
Springer-Verlag
Publication Date
Jun 01, 2016
Volume
43
Issue
9
Pages
1571–1573
Identifiers
DOI: 10.1007/s00259-016-3430-5
Source
Springer Nature
License
Yellow
Report this publication

Statistics

Seen <100 times